SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development…
POLITICS: Medical Marijuana Company Slams DEA In Lawsuit Alleging Extreme Delays To Cannabis Research LicensingWASHINGTON, D.C. / ACCESSWIRE / September…
STOCKHOLM, SE / ACCESSWIRE / September 20, 2023 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR),…
STOCKHOLM, SE / ACCESSWIRE / September 20, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") is pleased to…
EU Patent #19846183.2 - A NOVEL BOTANICAL AND TETRAHYDROCANNABINOL ("THC") FORMULATION FOR THE REDUCTION OF CANNABIS-INDUCED NEGATIVE NEUROPSYCHIATRIC SIDE-EFFECTSWe believe…
Phytome has partnered with Inventronics and the University of Plymouth to develop a series of data-driven "smart" controlled environment solutions…
New Module Automates Regulatory Updates During Corporate TransitionsLOS ANGELES, CA / ACCESSWIRE / September 19, 2023 / Today, LighthouseAI™, a…
SPARKS, NV / ACCESSWIRE / September 19, 2023 / Ludwig (OTC:LUDG), a provider of innovative medical technologies, announced today Marvin…
- Research study demonstrates regulation of chromatin structure and cancer gene expression – - Findings to augment clinical trial in…
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023…